Introduction and Objective
Nephrocalcinosis (NC) is commonly present in primary hyperparathyroidism (HPT), distal renal tubular acidosis (dRTA), and medullary sponge kidney disease (MSKD) but has not been studied in patients with CaP stones who do not have systemic disease.
Methods
We studied patients undergoing percutaneous nephrolithotomy (PNL) who had CaP or CaOx stones and did not have HPT, dRTA, or MSKD. On post-op (PO) day 1, all patients underwent a non-contrast CT scan. If there were no residual calcifications, the patient was categorized as not having NC. If there were residual calcifications, the patient underwent a secondary PNL. If the calcifications were found to be stones then the patient was categorized as not having NC. If the calcifications were not stones then the patient was categorized as having NC. Patients were grouped based on the type of stones they formed: hydroxyapatite (HASF), brushite (BRSF), and idiopathic calcium oxalate (ICSF). The extent of NC was quantified: 0=absence of NC and 3=extensive NC. Patients with residual calcifications on PO day 1 NCCT scan who did not undergo secondary PNL were excluded. The presence or absence of NC was correlated with metabolic studies.
Results
67 patients were studied (14 HASF, 19 BRSF, and 34 ICSF). NC was present in 10/14 (71.4%), 11/19 (57.9%) and 6/34 (17.6%) for the HASF, BRSF, and ICSF groups respectively (Chi-square (X2): p=0.01) (Table 1). The extent of NC per group was 1.98, 1.32, and 0.18 for HASF, BRSF, and ICSF respectively (p=<0.001). The presence of NC was positively correlated with urine calcium excretion (287.39±112.49 v. 223.68±100.67, p=0.03).
Conclusions
Patients without systemic disease who form hydroxyapatite and brushite stones commonly have coexistent NC. NC can occur in calcium oxalate stone formers but the quantity and frequency of NC in this group is dramatically less.